Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|May 25, 2004
Radioimmunotherapy for NHL: experience of 90Y-ibritumomab tiuxetan in clinical practiceAnton HagenbeekEuropean Journal of Haematology. Supplementum|January 9, 2007
The therapeutic use of rituximab in non-Hodgkin's lymphomaRobert Marcus, Anton HagenbeekSeminars in Hematology|March 31, 2010
CD20-targeted therapy: the next generation of antibodiesTom van Meerten, Anton HagenbeekBest Practice & Research. Clinical Haematology|June 11, 2011
Novel antibodies against follicular non-Hodgkin's lymphomaTom van Meerten, Anton HagenbeekHaematologica|August 30, 2008
B-cell involvement in chronic graft-versus-host diseaseRick Kapur, Saskia Ebeling, Anton HagenbeekLeukemia & Lymphoma|September 7, 2010
Diversity in antibody-based approaches to non-Hodgkin lymphomaDavid Maloney, Franck Morschhauser, Ola Linden, et al.Human Gene Therapy|January 29, 2002
Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in ratsMo Weijtens, Anke van Spronsen, Anton Hagenbeek, et al.Ecancermedicalscience|April 18, 2018
Untire: an all-embracing self-management eHealth program to cope with cancer-related fatigueAbraham Johannes Kuiper, Maria Dorothea Jacoba Wolvers, Dora Vonk, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Dosimetry of 90Y-ibritumomab tiuxetan as consolidation of first remission in advanced-stage follicular lymphoma: results from the international phase 3 first-line indolent trialAngelika Bischof Delaloye, Cristian Antonescu, Thomas Louton, et al.Pageof 6